Thomas G. Wiggans

CIK: 0001208907

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

JSPR

Jasper Therapeutics, Inc.

Director

PCRX

Pacira BioSciences, Inc.

Director

ANNX

Annexon, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

JSPR
Jasper Therapeutics, Inc.
Jul 31, 2026
Award(A)
Stock Option (Right to Buy
Direct
7.5K shares-
PCRX
Pacira BioSciences, Inc.
Jun 10, 2026
Award(A)
Stock Option (Right to Buy)
Direct
32.7K shares-
JSPR
Jasper Therapeutics, Inc.
Sep 22, 2025
Purchase(P)
Indirect
41K shares at avg. $2.43$100K
JSPR
Jasper Therapeutics, Inc.
Jul 3, 2025
Award(A)
Stock Option (right to buy)
Direct
7.5K shares-
ANNX
Annexon, Inc.
Jun 5, 2025
Award(A)
Stock Option (Right to Buy)
Direct
55K shares-

		Type	Shares	Price		Ownership
Jul 31, 2026	JSPR Jasper Therapeutics, Inc.	Award(A) Stock Option (Right to Buy	7,500	-	-	Direct
Jun 10, 2026	PCRX Pacira BioSciences, Inc.	Award(A) Stock Option (Right to Buy)	32,675	-	-	Direct
Sep 22, 2025	JSPR Jasper Therapeutics, Inc.	Purchase(P)	41,000	$2.43	$99,630	Indirect
Jul 3, 2025	JSPR Jasper Therapeutics, Inc.	Award(A) Stock Option (right to buy)	7,500	-	-	Direct
Jun 5, 2025	ANNX Annexon, Inc.	Award(A) Stock Option (Right to Buy)	55,000	-	-	Direct

1-5 of 5 transactions

About WIGGANS THOMAS G

WIGGANS THOMAS G (SEC CIK 0001208907) files insider reports with the SEC as Director of Jasper Therapeutics, Inc. (JSPR), Director of Pacira BioSciences, Inc. (PCRX) and Director of Annexon, Inc. (ANNX).

Signal8 holds 6 ownership filings by WIGGANS THOMAS G (1 Form 3, 5 Form 4), filed between Jun 9, 2025 and Aug 4, 2026. Those filings report 5 transactions, from Jun 5, 2025 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on WIGGANS THOMAS G's filings is in REDWOOD CITY, CA.

Recent filings by WIGGANS THOMAS G

Jul 31, 2026: Grant or award of JSPR derivative securities (Form 4, code A).
Jun 10, 2026: Grant or award of PCRX derivative securities (Form 4, code A).
Sep 22, 2025: Open-market purchase of JSPR shares (Form 4, code P).
Jul 3, 2025: Grant or award of JSPR derivative securities (Form 4, code A).
Jun 5, 2025: Grant or award of ANNX derivative securities (Form 4, code A).

Other insiders filing for Jasper Therapeutics, Inc. (JSPR)

Lucas Svetlana, Director
Crutcher Patrick J, Director
EMSTER KURT VON, Director
Shizuru Judith Anne, Director
Keenan Greg, Chief Medical Officer
Ros Matthew E, Chief Operating Officer

How to read Form 4 transaction codes